![](/img/cover-not-exists.png)
Rituximab, lenalidomide and pembrolizumab in refractory primary cutaneous diffuse large B‐cell lymphoma, leg type
Di Raimondo, Cosimo, Abdulla, Farah R., Zain, Jasmine, Querfeld, Christiane, Rosen, Steven T.Volume:
187
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.16211
Date:
November, 2019
File:
PDF, 10.00 MB
2019